While CRMP2 has been studied rather extensively in its role in neuronal trafficking, polarization, and differentiation, and has been associated with CLN6 and Batten disease features, there has been limited study in its use as a therapeutic target in neurodegenerative diseases [7,8]. Here, CLN6 is linked to juvenile neuronal ceroid lipofuscinosis.